Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Journal of Hematotherapy|April 7, 1999
Reproducible scoring of CFU-GM and BFU-E grown in collagen-based semisolid medium after a short (3 h) trainingI Dobo, J M Bidet, S Acquart, et al.
Leukemia|November 21, 1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemiaL Sutton, K Maloum, H Gonzalez, et al.
Annales De Medecine Interne|January 1, 1996
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]B Rio, Z Marjanovic, R Belhocine, et al.
Oncogene|August 16, 2016
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohortM Apicella, C Migliore, T Capelôa, et al.
Bone Marrow Transplantation|October 19, 2004
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphomaD Decaudin, J-M Vantelon, J-H Bourhis, et al.
Oncogene|January 20, 2009
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cellsM R Finkbeiner, A Astanehe, K To, et al.
ESMO Open|February 5, 2025
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE studyC Antoniotti, M Carullo, D Rossini, et al.
Pageof 23